inclusion criteria: * clinical scenario compatible with infection by the sars-cov-2 \[characteristic symptoms of covid-19 (fever and / or cough and / or fatigue) * beginning 1 to 3 days before inclusion in the study * age equal or superior to 18 years * willingness to receive study treatment * providing written and informed consent or the same consent signed by a family member

inclusion criteria: * clinical scenario compatible with infection by the sars-cov-2 \[characteristic symptoms of covid-19 (fever and / or cough and / or fatigue) * beginning 1 to 3 days before inclusion in the study * age equal or superior to 18 years * willingness to receive study treatment * providing written and informed consent or the same consent signed by a family member

inclusion criteria: - clinical scenario compatible with infection by the sars-cov-2 [characteristic symptoms of covid-19 (fever and / or cough and / or fatigue) - beginning 1 to 3 days before inclusion in the study - age equal or superior to 18 years - willingness to receive study treatment - providing written and informed consent or the same consent signed by a family member

inclusion criteria: - clinical scenario compatible with infection by the sars-cov-2 [characteristic symptoms of covid-19 (fever and / or cough and / or fatigue) - beginning 1 to 3 days before inclusion in the study - age equal or superior to 18 years - willingness to receive study treatment - providing written and informed consent or the same consent signed by a family member